Clinical Trials Sponsored by Population Welfare Department, Government of Sindh, Pakistan
Total 1 results
-
FHI 360United States Agency for International Development (USAID); Aga Khan University and other collaboratorsCompleted
Sponsors and Collaborators
- Caritas Freetown
- University Medical Center Goettingen
- Diego Hernan Giunta, MD
- The Fifth Affiliated Hospital of Zunyi Medical College
- AMTC & Associates
- CRMBM-CEMEREM
- Victor Montori
- Rui-hua Xu, MD, PhD
- Elim Pediatric Pharmaceuticals Inc.
- Alberta Children's Hospital, Calgary, Canada
- Cardresearch
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- San MediTech(Huzhou)Co.,Ltd.
- Norsk Proteinintolerance, Norway
- Societa Italiana di Endoscopia Digestiva
- ProteoSys AG
- Fondren Orthopedic Group L.L.P.
- Donders Institute for Brain, Cognition and Behavior
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- Celtaxsys Aus Pty Limited
- View Full List
Medical Conditions
- Tularaemia
- Tube Disorders Eustachian
- Gynecologic Cancer
- Non-dystrophic Myotonias
- Auditory Hallucination, Verbal
- Fever, Sweats, and Hot Flashes
- Postcomatose Unawareness State
- Malignant Ascites Due to Epithelial Carcinoma
- Disturbance of Activity and Attention
- Atrial Fibrillation, Postoperative
- Lymphedema of Arm
- Stereotactic Radioablation for Ventricular Tachycardia
- Orbital Tumor
- Normal Diameter of Optic Nerve
- Fibromyalgia Syndrome, Primary
- Spermatogenesis Arrest
- Prostate Cancer Recurrent
- Plasmodium Falciparum Malaria (Drug Resistant)
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Non-compressible Torso Hemorrhage
- View Full List
Drug Interventions
- Enzalutamide, Abiraterone
- Cetrorelix 78 mg + 78 mg
- Polyethylene glycol 3350
- SERETIDE Diskus
- Topotecan
- Lamivudine
- Indoximod
- Insulin
- Flibanserin 100 mg dose every evening
- Epimedium Prenylflavonoids Extract
- Cytarabine ARA-C
- Atezolizumab
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Ruxolitinib
- Bortezomib/dexamethasone
- Mupirocin Calcium
- PF-00868554
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Oxycodone, fentanyl
- Methotrexate
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Brazil
- Contract Research Organizations in Burundi
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Netherlands
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Peru
- Contract Research Organizations in Saint Lucia
- CRO list by country